China Vaccine Maker Inks Canada Deal to Develop Second Shot

(Bloomberg) -- Leading Chinese vaccine developer CanSino Biologics Inc. has inked a deal to test and sell a separate Canadian vaccine candidate as the race for immunization intensifies globally.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.